News & Events about Quanterix Corporation.
Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced financial results for the fourth quarter and twelve months ended December 31, 2022. This press release features multimedia. View the full release here...
Quanterix (NASDAQ:QTRX) is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the announcement.
Analysts estimate that Quanterix will report an earnings per share (EPS) of $-0.42.
read more...
Invesco Ltd. raised its holdings in shares of Quanterix Co. (NASDAQ:QTRX Get Rating) by 37.6% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 632,987 shares of the companys stock after acquiring an additional 173,042...
Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that Karen A. Flynn, Senior Vice President and Chief Commercial Officer of Catalent Pharma Solutions (NYSE: CTLT), has been appointed to...